NEWS
NanoGroup S.A. files further patent applications: for the innovative NanOX perfusion fluid and a blood substitute
Summary of NanoGroup’s activities to date in obtaining grant funding for the development of research projects
MEDIA
CONTACT FOR MEDIA

Anna Redwan
Chief Corporate affairs & communication
+48 601 316 313
a.redwan@nanogroup.eu